Filtered By:
Specialty: Infectious Diseases
This page shows you your search results in order of date. This is page number 2.
Order by Relevance | Date
Total 11695 results found since Jan 2013.
CROI 2023: Summary of Basic Science Research in HIV
Top Antivir Med. 2023 Jun 30;31(4):523-528.ABSTRACTThe 2023 Conference on Retroviruses and Opportunistic Infections (CROI) represented the first fully in-person conference since the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic began. CROI continues as the premier conference in which delegates can appraise themselves of almost every facet of HIV/AIDS research as well as emerging and re-emerging pathogens such as SARS-CoV-2 and mpox. The return to an in-person format is particularly important for early-stage investigators, who were faced with challenges of advancing their independent research careers...
Source: Topics in antiviral medicine - September 13, 2023 Category: Infectious Diseases Authors: Mario Stevenson Source Type: research
Clinical and epidemiological factors causing longer SARS-CoV 2 viral shedding: the results from the CoviCamp cohort
DiscussionOur analysis showed that CKD is a factor related to longer time-to-negative swab, probably because of immunosuppression related to this condition.
Source: Infection - September 13, 2023 Category: Infectious Diseases Source Type: research
Clusters of SARS-CoV-2 Infection Across Six Schools for Students with Intellectual and Developmental Disabilities
ConclusionThe Omicron variant led to an increase in cluster-based transmission, and staying up to date with vaccination guidelines was crucial in limiting transmission.Clinical Trial RegistrationPrior to enrollment, this study was registered at ClinicalTrials.gov on September 25, 2020 (identifier NCT04565509; titled “Supporting the Health and Well-being of Children with Intellectual and Developmental Disability During COVID-19 Pandemic”).
Source: Infectious Diseases and Therapy - September 13, 2023 Category: Infectious Diseases Source Type: research
Clinical and epidemiological factors causing longer SARS-CoV 2 viral shedding: the results from the CoviCamp cohort
DiscussionOur analysis showed that CKD is a factor related to longer time-to-negative swab, probably because of immunosuppression related to this condition.
Source: Infection - September 13, 2023 Category: Infectious Diseases Source Type: research
Safety and Immunogenicity of the BNT162b2 Vaccine Coadministered with Seasonal Inactivated Influenza Vaccine in Adults
ConclusionsBNT162b2 coadministered with SIIV elicited immune responses that were noninferior to those elicited by BNT162b2 alone and SIIV alone, and BNT162b2 had an acceptable safety profile when coadministered with SIIV. The results of this study support the coadministration of BNT162b2 and SIIV in adults.Trial RegistrationClinicalTrials.gov registration: NCT05310084.
Source: Infectious Diseases and Therapy - September 12, 2023 Category: Infectious Diseases Source Type: research
Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review
J Family Community Med. 2023 Jul-Sep;30(3):161-170. doi: 10.4103/jfcm.jfcm_3_23. Epub 2023 Jul 24.ABSTRACTDespite the numerous reports of cutaneous manifestations associated with vaccines for coronavirus disease 2019 (COVID-19), the relationship between COVID-19 vaccines and cutaneous side effects remains unevaluated. In this review, we examine these manifestations and their management. Reported dermatoses included injection-site reaction (early and delayed), type I allergic reaction, morbilliform eruption, pityriasis rosea, Sweet syndrome, lichen planus, psoriasis, herpes zoster reactivation, erythema multiforme, Stevens-...
Source: Herpes - September 7, 2023 Category: Infectious Diseases Authors: Nouf F Bin Rubaian Abdullah A Aljalfan Serene R Almuhaidib Source Type: research
First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023
We describe 10 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant BA.2.86 detected in Denmark, including molecular characteristics and results from wastewater surveillance that indicate that the variant is circulating in the country at a low level. This new variant with many spike gene mutations was classified as a variant under monitoring by the World Health Organization on 17 August 2023. Further global monitoring of COVID-19, BA.2.86 and other SARS-CoV-2 variants is highly warranted.PMID:37676147 | PMC:PMC10486197 | DOI:10.2807/1560-7917.ES.2023.28.36.2300460
Source: Euro Surveill - September 7, 2023 Category: Infectious Diseases Authors: Morten Rasmussen Frederik Trier M øller Vithiagaran Gunalan Sharmin Baig Marc Bennedb æk Lasse Engbo Christiansen Arieh Sierra Cohen Kirsten Ellegaard Anders Fomsgaard Kristina Tr æholt Franck Nicolai Balle Larsen Tine Graakj ær Larsen Ria Lassauni è Source Type: research
Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review
J Family Community Med. 2023 Jul-Sep;30(3):161-170. doi: 10.4103/jfcm.jfcm_3_23. Epub 2023 Jul 24.ABSTRACTDespite the numerous reports of cutaneous manifestations associated with vaccines for coronavirus disease 2019 (COVID-19), the relationship between COVID-19 vaccines and cutaneous side effects remains unevaluated. In this review, we examine these manifestations and their management. Reported dermatoses included injection-site reaction (early and delayed), type I allergic reaction, morbilliform eruption, pityriasis rosea, Sweet syndrome, lichen planus, psoriasis, herpes zoster reactivation, erythema multiforme, Stevens-...
Source: Herpes - September 7, 2023 Category: Infectious Diseases Authors: Nouf F Bin Rubaian Abdullah A Aljalfan Serene R Almuhaidib Source Type: research
First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023
We describe 10 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant BA.2.86 detected in Denmark, including molecular characteristics and results from wastewater surveillance that indicate that the variant is circulating in the country at a low level. This new variant with many spike gene mutations was classified as a variant under monitoring by the World Health Organization on 17 August 2023. Further global monitoring of COVID-19, BA.2.86 and other SARS-CoV-2 variants is highly warranted.PMID:37676147 | DOI:10.2807/1560-7917.ES.2023.28.36.2300460
Source: Euro Surveill - September 7, 2023 Category: Infectious Diseases Authors: Morten Rasmussen Frederik Trier M øller Vithiagaran Gunalan Sharmin Baig Marc Bennedb æk Lasse Engbo Christiansen Arieh Sierra Cohen Kirsten Ellegaard Anders Fomsgaard Kristina Tr æholt Franck Nicolai Balle Larsen Tine Graakj ær Larsen Ria Lassauni è Source Type: research
